53 related articles for article (PubMed ID: 2322438)
1. Cytosolic free calcium dependent regulation of osteoclast bone resorbing activity.
Teti A; Colucci S; Grano M; Barattolo R; Argentino L; Zambonin Zallone A
Boll Soc Ital Biol Sper; 1990 Jan; 66(1):1-4. PubMed ID: 2322438
[TBL] [Abstract][Full Text] [Related]
2. Scanning electrochemical microscopy at the surface of bone-resorbing osteoclasts: evidence for steady-state disposal and intracellular functional compartmentalization of calcium.
Berger CE; Rathod H; Gillespie JI; Horrocks BR; Datta HK
J Bone Miner Res; 2001 Nov; 16(11):2092-102. PubMed ID: 11697806
[TBL] [Abstract][Full Text] [Related]
3. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
4. Different calcium sensitivity in osteoclasts on glass and on bone and maintenance of cytoskeletal structures on bone in the presence of high extracellular calcium.
Lakkakorpi PT; Lehenkari PP; Rautiala TJ; Väänänen HK
J Cell Physiol; 1996 Sep; 168(3):668-77. PubMed ID: 8816921
[TBL] [Abstract][Full Text] [Related]
5. Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells.
Kameda T; Mano H; Yamada Y; Takai H; Amizuka N; Kobori M; Izumi N; Kawashima H; Ozawa H; Ikeda K; Kameda A; Hakeda Y; Kumegawa M
Biochem Biophys Res Commun; 1998 Apr; 245(2):419-22. PubMed ID: 9571166
[TBL] [Abstract][Full Text] [Related]
6. Antithetic effects of ryanodine and ruthenium red on osteoclast-mediated bone resorption and intracellular calcium concentrations.
Ritchie CK; Strei TA; Maercklein PB; Fitzpatrick LA
J Cell Biochem; 1995 Oct; 59(2):281-9. PubMed ID: 8904321
[TBL] [Abstract][Full Text] [Related]
7. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor.
Mentaverri R; Kamel S; Wattel A; Prouillet C; Sevenet N; Petit JP; Tordjmann T; Brazier M
J Cell Biochem; 2003 Apr; 88(6):1145-56. PubMed ID: 12647297
[TBL] [Abstract][Full Text] [Related]
8. A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells.
Sugawara K; Hamada M; Hosoi S; Tamaoki T
Anal Biochem; 1998 Jan; 255(2):204-10. PubMed ID: 9451505
[TBL] [Abstract][Full Text] [Related]
9. Protein tyrosine kinase inhibitors increase cytosolic calcium and inhibit actin organization as resorbing activity in rat osteoclasts.
Kajiya H; Okabe K; Okamoto F; Tsuzuki T; Soeda H
J Cell Physiol; 2000 Apr; 183(1):83-90. PubMed ID: 10699969
[TBL] [Abstract][Full Text] [Related]
10. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
[TBL] [Abstract][Full Text] [Related]
11. Voltage dependent calcium channel expression in isolated osteoclasts.
Teti A; Grano M; Colucci S; Argentino L; Barattolo R; Miyauchi A; Teitelbaum SL; Hruska KA; Zambonin Zallone A
Boll Soc Ital Biol Sper; 1989 Dec; 65(12):1115-8. PubMed ID: 2560636
[TBL] [Abstract][Full Text] [Related]
12. A reappraisal of the effect of extracellular calcium on osteoclastic bone resorption.
Hall TJ
Biochem Biophys Res Commun; 1994 Jul; 202(1):456-62. PubMed ID: 8037747
[TBL] [Abstract][Full Text] [Related]
13. Ion channels and transporters in osteoclasts.
Supanchart C; Kornak U
Arch Biochem Biophys; 2008 May; 473(2):161-5. PubMed ID: 18406337
[TBL] [Abstract][Full Text] [Related]
14. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
Grassi F; Cristino S; Toneguzzi S; Piacentini A; Facchini A; Lisignoli G
J Cell Physiol; 2004 May; 199(2):244-51. PubMed ID: 15040007
[TBL] [Abstract][Full Text] [Related]
15. High extracellular calcium concentrations directly stimulate osteoclast apoptosis.
Lorget F; Kamel S; Mentaverri R; Wattel A; Naassila M; Maamer M; Brazier M
Biochem Biophys Res Commun; 2000 Feb; 268(3):899-903. PubMed ID: 10679302
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia is a major stimulator of osteoclast formation and bone resorption.
Arnett TR; Gibbons DC; Utting JC; Orriss IR; Hoebertz A; Rosendaal M; Meghji S
J Cell Physiol; 2003 Jul; 196(1):2-8. PubMed ID: 12767036
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
Väänänen K
Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow cells produce soluble factors that inhibit osteoclast activity.
Ninomiya JT; Bi Y; Banks MA; Lavish SA; Goldberg VM; Greenfield EM
J Orthop Res; 1999 Jan; 17(1):51-8. PubMed ID: 10073647
[TBL] [Abstract][Full Text] [Related]
19. The relationship between calcium accumulation in osteoclast mitochondrial granules and bone resorption.
Kawahara I; Koide M; Tadokoro O; Udagawa N; Nakamura H; Takahashi N; Ozawa H
Bone; 2009 Nov; 45(5):980-6. PubMed ID: 19631304
[TBL] [Abstract][Full Text] [Related]
20. Activation of the Ca2+ "receptor" on the osteoclast by Ni2+ elicits cytosolic Ca2+ signals: evidence for receptor activation and inactivation, intracellular Ca2+ redistribution, and divalent cation modulation.
Shankar VS; Bax CM; Bax BE; Alam AS; Moonga BS; Simon B; Pazianas M; Huang CL; Zaidi M
J Cell Physiol; 1993 Apr; 155(1):120-9. PubMed ID: 8385675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
